ArticleCancer prevention research (Philadelphia, Pa.)2020

Combination of Erlotinib and Naproxen Employing Pulsatile or Intermittent Dosing Profoundly Inhibits Urinary Bladder Cancers.

Altaf Mohammed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.